top of page

Drug Shortage

Stay informed about the shortage, its impacts, and what you can do.




If you've had any trouble getting your prescription filled in the past 18 months, please join Dr. McCArthy and use your voice to call for an end to the shortage nonsense .


If you have submitted a refill request to Dr. McCarthy but nothing is ready at the pharmacy after the two-business-day processing time, be sure to:

1. Call your pharmacy and ask:

 ☑️ Has Dr. McCarthy's request been received?

2. Keep Dr. McCarthy informed by calling (703-288-3535)

☑️ Is the medication in stock?

Dr. McCarthy's screen may indicate a successfully submitted prescription request, but a system backlog at the pharmacy may block it from ever reaching the pharmacist.



..patients and their parents often spend hours or days calling different stores. Sometimes one store said they have stock, but it was out by the time they arrived to pick the medication up..


“It’s creating stress in an environment where I need to reduce stress,” Nicole said. “I realize nobody can do anything for me, and it’s going to be okay, but I’ve had to spend a lot of time on the phone with six different parties and advocate for myself and that’s kind of tough to do when you’re struggling.”


When I write a prescription, and it's not available in this particular pharmacy, they cannot just transfer the prescription. I have to write a new prescription, send it to the second pharmacy. And then, if the second pharmacy runs out, I have to rewrite the prescription, send it to the third pharmacy. It's a lot of hours that I just waste . . . writing prescriptions.



The D.E.A. is probably being especially strict on ADHD drug availability because it raised quotas during the opioid crisis — and was blamed for increased overprescribing. Now, it may be overcorrecting and worsening shortages.

The House Democrats asked what the [FDA and DEA] are doing to work with manufacturers and get them to fill their quotas. They further asked how the DEA will use lessons from the COVID-19 pandemic to update telemedicine prescribing rules


Write a Letter

A Way You Can Address the Medication Shortage: Write a Letter

March 18, 2024

Children and Adults with ADHD (CHADD)

Sample Letter with links to find your representatives

The Empty Adderall Factory

February 19, 2024


A drugmaker’s feud with the DEA is exacerbating the ADHD meds crisis — at a rate of 600 million missing doses a year.

‘I’m fed up’: Frustrations grow as ADHD drug shortage continues

February 6, 2024

NBC News

More than a year after the Food and Drug Administration announced a nationwide shortage of Adderall, doctors and patients say they are still struggling to get their hands on ADHD medications. Despite repeated promises from drugmakers that the supply crunches would be resolved soon, shortages persist, and frustration is growing.

House Democrats demand answers on year-long Adderall shortage

October 12, 2023

The Hill

A group of House Democrats is calling on the Food and Drug Administration (FDA) to explain what the agency is doing to address the shortage of Adderall in the U.S. that was declared exactly one year ago [in October 2022]

Opioid Settlement Hinders Patients’ Access to a Wide Array of Drugs

March 14, 2023

The New York Times

Nearly a year after a sweeping opioid settlement imposed new requirements on the companies that provide medications to pharmacies, patients across the United States are having difficulty obtaining drugs to treat many conditions, including anxiety, attention deficit hyperactivity disorder and addiction.

How a health-care cyberattack may affect your prescription drug access

March 5, 2024

The Washington Post

A cyberattack on a health-care company has created problems for many patients trying to fill drug prescriptions. For some consumers, the hack has forced them to pay cash for expensive drugs, denied their use of pharmaceutical discount coupons or left them unable to get their refills at all.

"A horrible, perfect storm": Frustrations rise as shortage of Adderall, other ADHD medication continues

February 12, 2024

The Chicago Tribune

All Jennifer Howell wanted was to find medication for her son. Instead, she was caught in a maze of desperate phone calls to pharmacies and physicians.

No end in sight for ADHD medication shortages

January 30, 2024

WSYR-TV, Syracuse NY

It has been over a year since the FDA reported the initial medication shortage, Adderall due to a manufacturer delay, and today multiple medications including generic equivalents can be just as hard to come by with no end in sight.

The A.D.H.D. Drug Shortage Is Causing Real Pain

October 9, 2023

The New York Times

Each manufacturer has a specific limit and the D.E.A. claims that some have extra doses that they could sell. Individual companies, in turn, say that the issue is that the D.E.A. won’t raise their particular quota and they don’t have enough to meet demand.

The Adverse Health Outcomes, Economic Burden, and Public Health Implications of Unmanaged Attention Deficit Hyperactivity Disorder (ADHD):

October 7, 2019

Children and Adults with ADHD (CHADD)

A Call to Action to Improve the Quality of Life and Life Expectancy of People with ADHD

FTC, HHS Request Patient Information on Drug Shortages, Pharmaceutical Middlemen

February 21, 2024

ADDittude Magazine

As the ADHD medication shortage drags on, the Federal Trade Commission and U.S. Department of Health and Human Services seek public input on how pharmaceutical intermediaries may influence drug prices and availability.

Why is there an ADHD medication shortage in 2024? What's making generics of Vyvanse, Adderall and more so scarce

February 8, 2024

CBS News

Supply from drugmakers for the stimulant medications most commonly prescribed for ADHD are still falling short of demand, the Food and Drug Administration says, and many Americans who rely on these treatments are wondering why the nationwide shortage is continuing into its second year.

DEA, Drug Manufacturers Trade Blame for Generic Adderall, Vyvanse Shortages

December 8, 2023

ADDittude Magazine

As the generic Adderall shortage extends to Vyvanse and Ritalin, the DEA says it has taken steps to increase ADHD medication production and transparency while drug manufacturers claim the federal agency’s production quotas are causing the treatment crisis.

Joint letter to Americans by the heads of the FDA and DEA

August 1, 2023

The FDA and DEA

Given the interest related to access to these medications, we want to provide an update on the ongoing actions being taken to resolve the shortages of prescription stimulant medications.

bottom of page